logo
A wasting disease killed millions of sea stars. After years of searching, scientists just found a cause.

A wasting disease killed millions of sea stars. After years of searching, scientists just found a cause.

Yahoo12 hours ago
'It was like a battleground,' Drew Harvell remembers. 'It was really horrible.'
She's reflecting on a time in December 2013, on the coast of Washington state, when she went out at low tide and saw hundreds of sick, dying sea stars. 'There were arms that had just fallen off the stars,' she says. 'It was really like a bomb had gone off.'
The stars were suffering from something known as sea star wasting disease. It's a sickness that sounds like something out of a horror movie: Stars can develop lesions in their bodies. Eventually, their arms can detach and crawl away from them before the stars disintegrate completely.
Harvell is a longtime marine ecologist whose specialty is marine diseases. And she was out for this low tide in 2013 because a massive outbreak of this seastar wasting had started spreading up and down the West Coast — from Mexico to Alaska — ultimately affecting around 20 distinct species of sea stars and wiping out entire populations in droves. In the decade since, some species have been able to bounce back, but others, like the sunflower sea star, continue to struggle. In California, for example, sunflower stars have almost completely died out.
The question in 2013 was: What, exactly, was killing all these stars? While marine ecologists like Harvell could recognize the symptoms of seastar wasting, they weren't actually sure what was causing the disease. From the very beginning, though, it was something they wanted to figure out. And so, soon after the outbreak started, they collected sea stars to see if they could find a pathogen or other cause responsible for the wasting. The hunt for the culprit of this terrible, mysterious disease was on.
Unfortunately, it was not straightforward.
' When this disease outbreak happened, we knew quite little about what was normal [in sea stars],' says Alyssa Gehman, who is also a marine disease ecologist. She says that when researchers are trying to do similar work to chase down a pathogen in, say, humans, they have an enormous trove of information to draw on about what bacteria and viruses are common to the human body, and what might be unusual. Not so for sea stars. ' We maybe had a little bit of information, but absolutely not enough to be able to really tease that out easily.'
Also, Gehman says, there can be a lag before the disease expresses itself, so some stars have the pathogen that caused the disease, but don't present with symptoms yet, making it harder for scientists to even distinguish between sick stars and healthy ones as they run their tests.
So even though a research team identified a virus that they thought might be associated with the wasting disease as early as 2014, over time, it became clear that it was most likely not the culprit, but rather just a virus present in many sea stars.
'The results were always confusing,' Harvell remembers.
In the decade since the initial mass outbreak, other researchers have proposed other theories, but none have brought them to a definitive answer either. And yet, it became increasingly clear that an answer was needed, because people started to realize just how important the sunflower stars they had lost really were.
' We actually learned a lot from losing so many of these animals at once,' Gehman says.
Before the outbreak, she says, they'd known that sunflower stars — giant sea stars that can be the size of dinner plates, or even bike tires — were skillful hunters and voracious eaters. They even knew that many things on the seafloor would run away from them. Gehman remembers taking a class on invertebrates back in college, where she learned that if you put even just the arm of a sunflower star in a tank with scallops, 'the tank would explode with scallops swimming everywhere trying to get away.'
But all that fearsome hunting was, it seems, pretty key to ecosystem health. In many places, she says, ' after the sea sunflower stars were lost, the urchin populations exploded.'
And so the die-off of the sunflower star and the explosion of urchins has been connected to the collapse of the Northern California kelp forests, a marine ecosystem that provides a home for a rich diversity of species.
A cross-state, cross-organizational partnership between the Nature Conservancy and a variety of research institutions is working hard to breed sunflower seastars in captivity in the hopes that they can be reintroduced to the coast and reassume their role in their ecosystems. But as Harvell remembers, she and Gehman knew that no recovery project would be successful if they couldn't find the cause of sea star wasting disease.
'You're not gonna be able to get these stars back in nature if you don't know what's killing them,' she says.
So in 2021, as part of the larger partnership, Harvell and Gehman, along with a number of their colleagues, launched into an epidemiological detective project. Their quest: to finally pin down the cause of seastar wasting disease.
'Really the work over the four years was done in the trenches by Dr. Melanie Prentice and Dr. Alyssa Gehman,' Harvell says, 'and then one of my students, Grace Crandall.'
It was an emotionally difficult project because it required Gehman and her colleagues to deliberately infect many stars with the disease.
'It feels bad,' she admits, and they would be open about that in the lab, 'but we also can remember that we're doing this for the good of the whole species.'
That work has paid off, though, and now, after four years of research, they've nailed their culprit in a paper out in Nature Ecology & Evolution today.
What follows is a conversation with Drew Harvell, edited for clarity and length, about what she and her collaborators found, how marine ecologists do this kind of detective work, and what identifying the culprit could mean for the future health of seastars.
How did you start the journey to figure out what actually had happened?
Well, we chose to work with the sunflower star because we knew it was the most susceptible and therefore was going to give us the most clear-cut results. So we set up at Marrowstone Point, which was the USGS Fisheries virus lab [in Washington state], because that would give us the proper quarantine conditions and lots of running seawater.
The proper quarantine conditions — what does that mean?
All of the outflow water has to be cleansed of any potential virus or bacterium, and so all of the water has to be run through virus filters and also actually bleached in the end, so that we're sure that nothing could get out.
We did not want to do this work at our lab, Friday Harbor Labs, or at any of the Hakai labs in Canada because we were really worried that if we were holding animals with an infectious agent in our tanks without really stringent quarantine protocols, that we could be contributing to the outbreak.
So you have these sea stars. They're in this quarantined environment. What is the methodology here? What are you doing to them or with them?
So the question is: Is there something in a diseased star that's making a healthy star sick? And that's like the most important thing to demonstrate right from the beginning — that it is somehow transmissible.
And so Melanie and Alyssa early on showed that even water that washed over a sick star would make healthy stars sick, and if you co-house them in the same aquarium, the healthy ones would always get sick when they were anywhere near or exposed to the water from a diseased star.
There's something in the water.
That's right. There's something in the water. But they wanted to refine it a little bit more and know that it was something directly from the diseased star. And so they created a slurry from the tissues of the disease star and injected that into the healthy star to be able to show that there really was something infectious from the disease star that was making the healthy star sick and then die.
And then you control those kinds of what we call 'challenge experiments' by inactivating in some way that slurry of infected disease stuff. And in this case, what they were able to do was to 'heat-kill' [any pathogens in this slurry] by heating it up. And so the thing that was very successful right from the beginning was that the stars that were infected with a presumptive disease got sick and died, and the controls essentially stayed healthy.
You do that control to make sure that it's not like…injecting a slurry into a star is what makes them sick?
That's right. And you're also having animals come in sick, right? So you want to know that they weren't just gonna get sick anyway. You want to be sure that it was what you did that actually affected their health status.
So you have a slurry — like a milkshake of sea star — and you know that within it is a problematic agent of some kind. How do you figure out what is in that milkshake that is the problem?
The real breakthrough came when Alyssa had the idea that maybe we should try a cleaner infection source and decided to test the coelomic fluid, which is basically the blood of the star. With a syringe, you can extract the coelomic fluid of the sick star and you can also heat-kill it, and you can do the same experiment challenging with that. And it was a really exciting moment because she and Melanie confirmed that that was a really effective way of transmitting the disease because it's cleaner.
It's cleaner, like there's less stuff than in the tissue? Like blood is just like a simpler material?
Right. So, that was really the beginning of being able to figure out what it was that was in the coelomic fluid that was causing the disease.
So basically it's like: … So it seems like it might be ingredient B that's causing the problem here because it's consistent across all samples?
Yeah, that's exactly it. And so then that was very, very incredibly exciting. Wow. There's this one bacterium — Vibrio pectenicida — that's showing up in all of the diseased material samples. Could it be that?
We weren't sure. We sort of thought, after 12 years, this is gonna be something so strange! So weird! You know, something alien that we've never seen before. And so to have a Vibrio — something that we think of as a little bit more common — turn up was really surprising.
Then one of our colleagues at the University of British Columbia, Amy Chan, was able to culture that particular bacterium from the disease star. And so now she had a pure culture of the presumptive killer. And then last summer, Melanie and Alyssa were able to test that again under quarantine conditions and find that it immediately killed the stars that were tested.
How did you all feel?
Oh, we were definitely dancing around the room. It was — just such a happy moment of fulfillment. I really do like to say that at the beginning of the task that Nature Conservancy handed us — to figure out the causative agent — we told them again and again that this is a very risky project. We can't guarantee we're going to be successful.
So yeah, we were incredibly elated when we really felt confident in the answer. It was just hundreds and hundreds of hours of tests and challenge experiments that came out so beautifully.
What does it mean to finally have an answer here? What are the next steps?
This was the part of it that really kept me awake at night because I just felt so worried early on at the idea that we were working on a roadmap to recovery of a species without knowing what was killing it, and I just felt like we couldn't do it if we were flying blind like that.
We wouldn't know what season the pathogenic agent came around. We wouldn't know what its environmental reservoirs were. We didn't know what was making stars susceptible. It was going to be really hard, and it wasn't going to feel right to just put animals out in the wild without knowing more.
And so knowing that this is one of the primary causative agents — maybe the only causative agent — allows us to test for it in the water. It allows us to find out if there are some bays where this is being concentrated, to find out if there are some foods the stars are eating that are concentrating this bacterium and delivering a lethal dose to a star.
Now we'll be able to answer those questions, and I think that's going to give us a really good opportunity to design better strategies for saving them.
It feels like you now have a key to use to sort of unlock various pieces of this.
We totally do. And it's so exciting and so gratifying because that's what we're supposed to do, right? As scientists and as disease ecologists, we're supposed to solve these mysteries. And it feels really great to have solved this one. And I don't think there's a day in the last 12 years that I haven't thought about it and been really frustrated we didn't know what it was. So it's particularly gratifying to me to have to have reached this point.
Drew Harvell is the author of many popular science books about marine biology and ecology, including her latest, The Ocean's Menagerie. She also wrote a book about marine disease called Ocean Outbreak.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Your Blood Type Might Be Why Mosquitoes Love You. A Doctor Explains Why
Your Blood Type Might Be Why Mosquitoes Love You. A Doctor Explains Why

CNET

time37 minutes ago

  • CNET

Your Blood Type Might Be Why Mosquitoes Love You. A Doctor Explains Why

Growing up in Puerto Rico, I was used to seeing my arms and legs covered in mosquito bites after a full day at the beach. There was no escaping them as the sun began to set; it was almost a rite of passage -- like it's a toll you pay to experience the glorious hues of pink and orange across the sky. What was once brushed off as a (mostly) harmless nuisance has become something you should pay closer attention to. As mosquito populations grow and climate patterns shift, doctors are seeing more people get seriously sick from diseases these tiny bugs carry. "Both globally and in the US, we have seen increasing cases of mosquito-borne illnesses over the past decade," says Dr. Scott Braunstein, chief medical officer at Sollis Health. While not every mosquito bite will lead to a severe disease, it's worth knowing the signs and how to protect yourself. According to Braunstein, here's what to look for. Did you know mosquitoes are the world's deadliest animal? Mosquitoes may be tiny, but they're responsible for more deaths than any other creature on the planet. According to the World Health Organization, more than 700,000 people die each year from vector-borne illnesses that can be caused by parasites, viruses or bacteria. That includes everything from malaria and dengue to Zika virus, yellow fever, chikungunya fever and other viral infections that are difficult to treat once contracted. Malaria alone caused nearly 600,000 deaths globally in 2023, mostly among children in Sub-Saharan Africa. Dengue affects roughly 390 million people annually, with around 20,000 deaths each year. And Zika virus, while rarely fatal, has been linked to severe congenital disabilities and neurological complications. Yellow fever, another mosquito-borne disease, can cause deadly liver failure in unvaccinated travelers. These illnesses aren't limited to tropical regions anymore. The viruses mosquitoes carry are expanding to new areas and reemerging in places they haven't been seen in decades. What are the most common mosquito-borne illnesses in the US? If you're in the US, the most likely mosquito-borne infections are West Nile virus and other types of encephalitis viruses (brain inflammation). Both can be mild, but in some cases, these infections can affect the brain and nervous system. Regarding travel-related cases, "Malaria, dengue and chikungunya are the most common," Braunstein says. "In the last few years in the US, we have seen sporadic increases of locally acquired cases of malaria and dengue." When to worry about your symptoms According to Braunstein, about 25% of people who get one of these illnesses from a mosquito bite will develop symptoms. The earliest signs tend to be subtle and flu-like: "most commonly fever, joint pain and headache." The more serious symptoms are harder to ignore and will require medical attention. "If you begin to feel weak or dizzy, short of breath or develop neck stiffness or confusion, these could be signs of infection reaching your spinal fluid, and it's critical to seek immediate emergency care," Braunstein says. Certain groups are more likely to develop severe illnesses, including children, older adults and people with compromised immune systems. Even your blood type can affect your likelihood of getting a mosquito bite. "People with Type O blood are the most attractive to mosquitoes, while those with Type A blood are the least attractive," Braunstein adds. "Mosquitos are attracted to warmer body temperatures, sweat and dark-colored clothing." Not all mosquito bites are created equal, but they look the same Identifying which mosquito bites are infectious from those that are not is where it starts to get tricky. You can't tell from looking at a bite whether it's harmless. "Mosquito bites generally look and feel the same, whether the mosquito is carrying a serious disease or not," Braunstein says. But if the area around the bite starts to swell rapidly, feels painful or shows signs of infection like pus or redness, that's a reason to check in with your doctor. The same can be said for full-body symptoms like fever, joint pain or hives, especially if you have trouble breathing. The size and severity of a bite relate to how your immune system responds to the saliva introduced by the mosquito when it bites. Suriyawut Suriya/EyeEm/Getty Images Tips to avoid mosquito bites, according to a doctor Here are some expert-approved tips to protect yourself from mosquito bites. Avoid being outside during peak hours The best way to protect yourself from mosquito-borne illnesses is to not get bitten in the first place. So your best bet is to avoid peak mosquito hours. "To avoid being feasted on by mosquitoes is to avoid being outdoors at the time they are most active -- dawn and dusk," Braunstein says. If you do need to be outside, covering up matters: Wearing thick clothes, with long sleeves and pant legs, preferably lighter-colored clothing, can be protective. Use a mosquito repellent Regarding repellents, either DEET or a plant-based repellent be effective. "The main proven difference is that DEET provides longer-lasting protection (up to 5 hours), while plant-based repellants lose their efficacy quickly and require more frequent reapplication (every 1 to 2 hours)," says Braunstein. He notes that the American Academy of Pediatrics recommends no higher than 30% DEET for children. Insect repellents are also not recommended for children younger than 2 months. Other mosquito repellent options you can consider: Clean up yourOne of the simplest ways to reduce mosquitoes in your home is to eliminate stagnant water. This includes flower pots, bird baths and pet water bowls, which should be cleaned and emptied frequently. Braunstein says, "These small pools are ideal breeding grounds for mosquitoes, especially in warm weather." How to stay on top of outbreaks If you want to stay ahead of outbreaks in your area, Braunstein recommends checking out ArboNET, a resource from the CDC that tracks mosquito-borne diseases across the US. The database includes human cases, infected mosquitoes and veterinary cases. I find it particularly helpful during travel or seasonal spikes. One last myth to ditch You've probably heard someone say mosquitoes prefer "sweet blood" or that people with diabetes are more likely to get bitten. According to Braunstein, that's not how it works. "People believe that mosquitoes prefer 'sweet blood,' for instance, after a high sugar meal or blood from those with diabetes," he says. "However, it has been shown that mosquitoes actually prefer the blood of people without diabetes, blood type O and are more attracted to carbon dioxide, lactic acid and ammonia in our sewers." So no, it's not your dessert they're after. It's your scent, sweat and carbon dioxide that attracts mosquitoes.

Signs Point To Possible Future Medicare Coverage Of Obesity Meds
Signs Point To Possible Future Medicare Coverage Of Obesity Meds

Forbes

timean hour ago

  • Forbes

Signs Point To Possible Future Medicare Coverage Of Obesity Meds

Signs are pointing in the direction of a near future in which Medicare beneficiaries will have at least some access to weight loss drugs. It's a two-pronged approach, though both pathways are independent of each other. First, there's a renewed bipartisan effort in Congress to lift the prohibition on coverage of obesity medications in Medicare. Second, the Trump administration announced the launch of a pilot project which could provide better access to obesity drugs. All things considered, however, getting the federal government program to pay for weight loss medications still won't be easy. Roughly 40% of adult Americans are considered obese. Obesity increases the risk of developing conditions such as diabetes, heart disease, osteoarthritis and some cancers. Rates of obesity have been steadily rising since 1980. Medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become popular as weight loss therapeutics. Taken in accordance with the instructions on the label and an appropriate diet and exercise regimen, GLP-1s are effective at lowering a person's weight. But Medicare doesn't allow coverage of weight loss medications that are strictly being used for obesity. It can only pay for them if they're prescribed for a related condition, such as diabetes or heart disease. Lawmakers have resubmitted different versions of a bill to permit such coverage numerous times since 2013. Senator Bill Cassidy (R-LA) reintroduced the Treat and Reduce Obesity Act this summer to 'combat the obesity crisis in the United States by providing regular screenings. The bill would also prevent diseases associated with obesity through expanded coverage of new healthcare specialists and chronic weight management medications for Medicare recipients.' However, it's this last item which would lift the 20-year prohibition on coverage that's been a limiting factor that has prevented previous versions of the legislation from passage. The cost of reimbursing these medications has often been cited as a stumbling block. The nonpartisan Congressional Budget Office, for instance, published projections late last year that estimated it would cost Medicare a cumulative $35 billion from 2026-2034 to cover anti-obesity medications. While CBO included savings from improved health, these were not nearly sufficient to offset the costs of the medications. Part of the problem is that patients who are treated with GLP-1s discontinue such treatments at a relatively high rate. One study, for example, found that approximately 53% of patients with overweight or obesity taking semaglutide-based followed for up to a year didn't persist on treatment past two months. The cost estimates used by the Centers for Medicare and Medicaid Services assume that a relatively high percentage of patients will stop taking them shortly after beginning their regimen. And so, there are still questions about whether this latest reintroduction of TROA will be successful. Moreover, even if the proposed legislation were to pass, enactment wouldn't happen until at least two years after passage. Another route is possible, via a regulatory pathway initiated by the executive branch. At the end of its tenure, the Biden administration proposed a regulatory change that would permit coverage of obesity drugs with some restrictions. Upon taking office, the Trump administration nixed the proposal. Nevertheless, it now intends to pursue a demonstration project under authority granted by the Affordable Care Act to experiment with models that seek to improve quality of care and lower costs. Under a Center for Medicare and Medicaid Innovation initiative, state Medicaid programs and Medicare outpatient drug (Part D) plans could soon voluntarily choose to cover obesity drugs for weight management, the Washington Post reported, citing documents from the Centers for Medicare and Medicaid. A Medicaid experiment would commence in Apr. 2026; Medicare in Jan. 2027. Timing for the Medicare portion of the planned model coincides with implementation of a maximum fair price for Wegovy in 2027. Together with Ozempic, another semaglutide-based product, Wegovy was selected for Medicare price negotiation earlier this year under an Inflation Reduction Act provision. Presumably, this would provide the federal government with an even lower net price than is currently attainable. Nonetheless, challenges lie ahead. The plan has not been finalized. Nor have any details been divulged. Without information on how prescription drug plans or Medicare Advantage insurers would be incentivized to sign up, it's unclear who would be interested in adding coverage. Aside from government-initiated changes, it's possible that certain commercial insurers and perhaps even some Medicaid payers will decide to revisit their coverage decisions if net costs decrease sufficiently, combined with more data showing the benefits of weight loss drugs when taken consistently and in conjunction with an appropriate nutrition regimen and physical activity. There's encouraging data in this regard which was posted in late June by the pharmacy benefits manager Prime Therapeutics. Recent initiators on high potency Wegovy and Zepbound—who started treatment in 2024—appear to be staying on their medications longer. The year-over-year persistence analysis found one-year persistence nearly doubling from 33.2% in 2021 to 62.7% in 2024. This in turn could confer improved, sustained benefits, in which case there would likely be less weight rebound upon discontinuation. But more research is needed to confirm the observed trend. Another thing that could galvanize payers towards targeted coverage is if they adopt an evidence-based approach that differentiates sub-populations by risk. All or nothing reimbursement makes little sense for insurers in both the commercial and public sectors. At current prices, most cost-effectiveness analyses fail to show cost savings except for when applied to high-risk groups, such as people with established cardiovascular disease, chronic kidney disease or severe obesity. A differentiated approach to access could also help mitigate costs for Medicare which in turn could serve as an impetus to pass legislation.

A red meat allergy from tick bites is spreading – and the lone star tick isn't the only alpha-gal carrier to worry about
A red meat allergy from tick bites is spreading – and the lone star tick isn't the only alpha-gal carrier to worry about

Yahoo

time2 hours ago

  • Yahoo

A red meat allergy from tick bites is spreading – and the lone star tick isn't the only alpha-gal carrier to worry about

Hours after savoring that perfectly grilled steak on a beautiful summer evening, your body turns traitor, declaring war on the very meal you just enjoyed. You begin to feel excruciating itchiness, pain or even swelling that can escalate to the point of requiring emergency care. The culprit isn't food poisoning – it's the fallout from a tick bite you may have gotten months earlier and didn't even notice. This delayed allergic reaction is called alpha-gal syndrome. While it's commonly called the 'red meat allergy,' that nickname is misleading, because alpha-gal syndrome can cause strong reactions to many products, beyond just red meat. The syndrome is also rapidly spreading in the U.S. and around the globe. The Centers for Disease Control and Prevention estimates as many as 450,000 people in the U.S. may have it. And it's carried by many more tick species than most people realize. What is alpha-gal syndrome? Alpha-gal syndrome is actually an allergy to a sugar molecule with a tongue-twisting name: galactose-alpha-1,3-galactose, shortened to alpha-gal. The alpha-gal sugar molecule exists in the tissues of most mammals, including cows, pigs, deer and rabbits. But it's absent in humans. When a big dose of alpha-gal gets into your bloodstream through a tick bite, it can send your immune system into overdrive to generate antibodies against alpha-gal. In later exposure to foods containing alpha-gal, your immune system might then launch an inappropriate allergic response. Often this allergy is triggered by eating red meat. But the allergy also can be set off by exposure to a range of other animal-based products, including dairy products, gelatin (think Jell-O or gummy bears), medications and even some personal care items. The drug heparin, used to prevent blood clotting during surgery, is extracted from pig intestines, and its use has triggered a dangerous reaction in some people with alpha-gal syndrome. Once you have alpha-gal syndrome, it's possible to get over the allergy if you can modify your diet enough to avoid triggering another reaction for a few years and also avoid more tick bites. But that takes time and careful attention to the less obvious triggers that you might be exposed to. Why more people are being diagnosed As an entomologist who studies bugs and the diseases they transmit, what I find alarming is how rapidly this allergy is spreading around the globe. Several years ago, experts thought alpha-gal syndrome was primarily limited to the southeastern U.S. because it was largely associated with the geographical range of the lone star tick. However, both local and global reports have now identified many different tick species across six continents that are capable of causing alpha-gal syndrome, including the prolific black-legged tick, or deer tick, which also transmits Lyme disease. These ticks lurk in yards and urban parks, as well as forests where they can stealthily grab onto hikers when they touch tick-infested vegetation. As tick populations boom with growing deer and human populations, the number of people with alpha-gal syndrome is escalating. Why ticks are blamed for alpha-gal syndrome There are a few theories on how a tick bite triggers alpha-gal syndrome and why only a small proportion of people bitten develop the allergy. To understand the theories, it helps to understand what happens as a tick starts feeding on you. When a tick finds you, it typically looks for a warm, dark area to hide and attach itself to your body. Then its serrated teeth chew through your skin with rapid sawing motions. As it excavates deeper into your skin, the tick deploys a barbed feeding tube, like a miniature drilling rig, and it secretes a biological cement that anchors its head into its new tunnel. Once secure, the tick activates its pumping station, injecting copious amounts of saliva containing anesthetics, blood thinners and, sometimes, alpha-gal sugars into the wound so it can feed undetected, sometimes for days. One theory about how a tick bite causes alpha-gal syndrome is linked to the enormous quantity of tick saliva released during feeding, which activates the body's strong immune response. Another suggests how the skin is damaged as the tick feeds and the possible effect of the tick's regurgitated stomach contents into the bite site are to blame. Or it may be a combination of these and other triggers. Scientists are still investigating the causes. What an allergic reaction feels like The allergy doesn't begin right away. Typically, one to three months after the sensitizing tick bite, a person with alpha-gal syndrome has their first, disturbing reaction. Alpha-gal syndrome produces symptoms that range from hives or swelling to crushing abdominal pain, violent nausea or even life-threatening anaphylactic shock. The symptoms usually start two to six hours after a person has ingested a meat product containing alpha-gal. Due to a general lack of awareness about the allergy, however, doctors can easily miss the diagnosis. A study in 2022 found that 42% of U.S. health care practitioners had never heard of alpha-gal syndrome. A decade ago, people with alpha-gal syndrome might go years before the cause of their symptoms was accurately diagnosed. Today, the diagnosis is faster in areas where doctors are familiar with the syndrome, but in many parts of the country it can still take time and multiple doctor visits. Unfortunately, with every additional tick bite or exposure to food or products containing alpha-gal, the allergy can increase in severity. If you think you have alpha-gal syndrome If you suspect you may have alpha-gal syndrome, the first step is to discuss the possibility with your doctor and ask them to order a simple blood test to measure whether your immune system is reacting to alpha-gal. If you test positive, the main strategy for managing the allergy is to avoid eating any food product from a mammal, including milk and cheese, as well as other potential triggers, such as more tick bites. Read labels carefully. Some products contain additives such as carrageenan, which is derived from red algae and contains alpha-gal. In extreme cases, people with alpha-gal syndrome may need to carry an EpiPen to prevent anaphylactic shock. Reputable websites, such as the CDC and can provide more information and advice. Mysteries remain as alpha-gal syndrome spreads Since alpha-gal syndrome was first formally documented in the early 2000s, scientists have made progress in understanding this puzzling condition. Researchers have connected the allergy to specific tick bites and found that people with the allergy can have a higher risk of heart disease, even without allergy symptoms. But important mysteries remain. Scientists are still figuring out exactly how the tick bite tricks the human immune system and why tick saliva is a trigger for only some people. With growing public interest in alpha-gal syndrome, the next decade could bring breakthroughs in preventing, diagnosing and treating this condition. For now, the next time you are strolling in the woods or in long grasses, remember to check for ticks on your body, wear long sleeves, long pants and tick repellent to protect yourself from these bloodthirsty hitchhikers. If you do get bitten by a tick, watch out for odd allergic symptoms to appear a few hours after your next steak or handful of gummy bears. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Lee Rafuse Haines, University of Notre Dame Read more: Ticks carry decades of history in each troublesome bite Ticks spread plenty more for you to worry about beyond Lyme disease Summertime can be germy: A microbiologist explains how to avoid getting sick at the barbecue, in the pool or on the trail Lee Rafuse Haines is affiliated with the Liverpool School of Tropical Medicine as an Honorary Fellow. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store